YOLFTbeta
71

YSP Southeast Asia Holding Bhd

7178 · KLSE · Healthcare / Drug Manufacturers - Specialty & Generic

1.95MYR+0.02 (+1.04%)

Price History

Full chart

Market Stats

Previous Close1.93
Open1.92
Day Range1.92 – 1.95
52-Week Range1.92 – 2.13
Volume21.80K
Market Cap273.76M
P/E (TTM)10.16
Forward P/E0.00
EPS0.19
Dividend Yield5.70%
Beta-0.01
50-Day Avg2.01
200-Day Avg2.06

About

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology and health products, as well as traditional herbal medicines, food and health supplements, and over-the-counter products; and offers management services. Y.S.P. Southeast Asia Holding Berhad was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. Fang-Hsin Lee
  • Employees1.36K
  • HeadquartersMenara LGB, Kuala Lumpur, Malaysia, 60000, Malaysia
  • Websitehttps://www.yspsah.com

Leadership

  • Dr. Fang-Hsin LeeGroup MD, President & Executive Director · b. 1960
  • Ms. Siew Wai YapMarketing Director · b. 1970
  • Ms. Seck Wah Lim MAICSACompany Secretary · b. 1959
  • Ms. Mei Kee Kong MAICSACompany Secretary
  • Chen Chun LaiExecutive
  • Ananda Prakash UlaganathenExecutive
  • Swee Poh GanExecutive
  • Weng Kong LimExecutive
  • Foong Heong NgExecutive
  • Swee Cheng PohExecutive

Financials

Income Statement

Currency: MYR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue181.00M191.00M202.00M223.00M237.06M261.56M288.76M295.62M297.06M281.86M334.25M355.00M368.66M365.12M
Growth (%)-+5.52%+5.76%+10.40%+6.31%+10.33%+10.40%+2.38%+0.49%-5.12%+18.59%+6.21%+3.85%-0.96%
Cost of Revenue98.00M106.00M111.00M119.00M131.41M142.93M153.32M165.03M172.29M170.20M189.80M200.78M212.29M204.03M
Gross Profit82.00M85.00M92.00M104.00M105.66M118.63M135.44M130.59M124.77M111.66M144.44M154.21M156.37M161.08M
Gross Margin45.30%44.50%45.54%46.64%44.57%45.35%46.90%44.18%42.00%39.62%43.21%43.44%42.42%44.12%
Operating Expense61.00M62.00M66.00M64.00M68.86M88.83M92.08M97.38M93.19M87.82M96.41M100.07M116.52M122.84M
Operating Income21.00M23.00M26.00M40.00M36.79M29.80M43.36M33.21M31.57M23.85M48.04M54.14M39.85M38.24M
Operating Margin11.60%12.04%12.87%17.94%15.52%11.39%15.02%11.23%10.63%8.46%14.37%15.25%10.81%10.47%
EBITDA-----41.00M54.57M48.38M47.21M40.39M64.65M71.75M58.24M57.14M
EBITDA Margin-----15.68%18.90%16.36%15.89%14.33%19.34%20.21%15.80%15.65%
Net Income14.00M16.00M16.00M29.00M27.59M20.38M30.35M23.01M21.98M15.18M34.47M37.31M26.69M25.03M
Net Income Margin7.73%8.38%7.92%13.00%11.64%7.79%10.51%7.78%7.40%5.39%10.31%10.51%7.24%6.86%
Interest Expense0000001.73M2.46M2.17M2.14M1.73M2.26M2.74M2.69M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.60%0.83%0.73%0.76%0.52%0.64%0.74%0.74%

Balance Sheet

Currency: MYR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets296.00M299.00M298.00M325.00M341.10M370.01M412.41M431.74M448.74M447.75M474.05M520.74M528.74M541.06M
Total Liabilities73.00M69.00M59.00M61.00M66.69M80.49M97.36M103.55M106.15M101.25M101.89M125.68M119.72M115.36M
Total Equity----274.41M289.51M315.05M328.19M342.60M346.50M372.16M395.06M409.02M417.87M
Cash51.00M60.00M44.00M50.70M30.53M75.20M32.36M40.62M44.95M120.40M129.51M78.92M58.73M148.10M
Total Debt------34.78M39.79M44.75M-----

Cash Flow

Currency: MYR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.00M30.00M14.00M27.00M41.90M27.60M20.20M32.58M9.07M63.63M48.31M36.33M49.71M54.46M
Investing Cash Flow-19.00M-1.00M-8.00M-7.00M-10.96M-12.07M-27.67M-2.29M-8.64M-2.75M-2.83M-33.73M-7.00M-2.21M
Financing Cash Flow-5.00M-20.00M-22.00M-11.00M-9.80M-11.63M8.34M-16.29M-2.98M-28.98M-37.63M290.00K-31.36M-38.64M
Capital Expenditure18.00M5.00M9.00M8.00M7.84M9.39M29.00M3.90M10.01M3.42M4.42M35.78M9.07M4.30M
Free Cash Flow-----18.21M-8.91M28.68M-942.00K60.05M43.96M550.00K40.64M50.16M
Dividends Paid---8.74M10.77M11.60M9.66M9.77M9.84M9.86M11.28M14.17M15.60M21.28M
FCF to OCF-----65.96%-44.11%88.04%-10.38%94.38%90.99%1.51%81.76%92.11%
Dividend Paid to FCF-----63.72%-108.37%34.07%-1044.59%16.42%25.66%2576.18%38.39%42.42%

Earnings

Report DateMar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Dec 31, 2005Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 16, 2016Nov 22, 2016Feb 22, 2017May 23, 2017Aug 16, 2017Nov 16, 2017Feb 28, 2018May 25, 2018Aug 29, 2018Nov 14, 2018Feb 26, 2019May 24, 2019Aug 29, 2019Nov 27, 2019Feb 26, 2020May 21, 2020Aug 25, 2020Nov 19, 2020Feb 24, 2021May 25, 2021Aug 20, 2021Nov 23, 2021Feb 25, 2022May 20, 2022Aug 23, 2022Nov 22, 2022Feb 27, 2023May 23, 2023Aug 22, 2023Nov 21, 2023Feb 27, 2024May 21, 2024Aug 28, 2024Nov 29, 2024Mar 4, 2025May 30, 2025Aug 26, 2025Nov 28, 2025Mar 4, 2026Mar 31, 2026
EPS Estimate-----------------------------------------------------------------------------------
EPS Actual0.030.030.010.050.040.060.040.060.040.020.060.050.050.020.050.030.030.030.030.030.030.040.040.030.040.040.030.030.020.020.030.030.030.030.040.010.020.050.070.030.070.050.040.050.030.090.060.020.020.040.050.070.050.050.030.050.060.030.040.080.000.030.020.030.030.030.050.080.080.040.080.090.040.060.100.020.020.040.080.010.040.050.07
Surprise-----------------------------------------------------------------------------------
Timing-----------------------------------------------------------------------------------

Key Statistics & Ratios

Market Cap273.76M
Enterprise Value168.78M
Trailing P/E10.16
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.74
Price / Book0.66
EPS0.19
Book Value2.99
Revenue (TTM)369.53M
Gross Profit (TTM)160.14M
EBITDA52.90M
Profit Margin7.31%
Operating Margin8.26%
Return on Equity6.42%
Return on Assets4.54%
Shares Outstanding141.84M
Shares Float44.52M
Beta-0.01
Dividend Yield5.70%
Dividend Rate0.11
Payout Ratio68.62%

Dividends

20261×
0.07Jun 26, 2026
20252×
0.04Dec 12, 20250.11Jun 25, 2025
20241×
0.03Jun 24, 2024
20231×
0.07Jun 26, 2023
20221×
0.01Jun 29, 2022
20211×
0.01Jul 14, 2021
20201×
0.01Jul 27, 2020
20191×
0.01Jun 27, 2019
20181×
0.07Jun 26, 2018
20171×
0.01Jun 28, 2017
20161×
0.01Jun 28, 2016
20151×
0.07Jul 23, 2015
20141×
0.07Jul 16, 2014
20131×
0.07Jul 16, 2013
20121×
0.06Jul 23, 2012
20111×
0.06Jul 6, 2011
20101×
0.06Jul 26, 2010
20091×
0.06Jun 29, 2009
20081×
0.06Jul 17, 2008
20071×
0.06Jul 10, 2007
20041×
0.05Aug 18, 2004

Stock Splits

  • Jul 8, 2011412:409
  • Jul 8, 200977:75
  • Jul 14, 200698163:89239
  • Aug 2, 200598163:89239